A cancer diagnosis can be a life-changing event, and it’s not uncommon for people with cancer to experience depression. Depression is a mood disorder that can cause a persistent feeling of sadness, hopelessness, and loss of interest in activities that were once enjoyable. It can also lead to changes in sleep, appetite, energy levels, and concentration.
Doctors have various expectations and needs from pharma companies but is pharma listening? First and foremost, they want ALL the data around new drugs and ongoing clinical trials but their needs go beyond that alone.
EHRs were supposed to make our medical records digital, so sharing them among physicians would not be an issue, but so far EHRs have yet to live up to the promises. Sharing medical records between doctors can be challenging for several reasons, such as..
Whether or not pharmaceutical companies have the right to charge a lot of money for prescription drugs is a complex question with no easy answer. There are a number of factors to consider, including the cost of research and development, the risk of failure, and the need to recoup costs.
Gun violence is a major health concern in the United States. It is a leading cause of death for people of all ages, and it disproportionately affects young people, people of color, and people living in poverty. Gun violence also has a significant impact on the mental and physical health of survivors and witnesses.
United Healthcare’s decision to request prior authorization for a colonoscopy could delay detection of GI health issues. From a doctor’s perspective, insurance prior authorization can have several negative effects on patients. Here are some ways it can harm patients:
The high price of new Alzheimer’s drugs will affect various stakeholders, including patients, healthcare systems, insurers, and the pharma industry. It will add billions to Medicare spending in a healthcare system trying to reduce costs. Here are some way it will impact our healthcare.
Lowering the price of prescription drugs is a complex issue. Still, there are several strategies that Medicare can consider to address this challenge, especially with a new Alzheimer’s drug that could cost taxpayers $5 billion. Here are some ways to lower Medicare costs.